259392320	259392320	CD	B-NP	O
|	|	NNP	I-NP	O
SEH	SEH	NNP	I-NP	O
|	|	VBD	B-VP	O
78863767	78863767	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8602812	8602812	CD	B-NP	O
|	|	CC	I-NP	O
7/18/2006	7/18/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEMATURIA	HEMATURIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/26/2006	1/26/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/19/2006	5/19/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BORGERDING	BORGERDING	NNP	B-NP	O
,	,	,	O	O
WESTON	WESTON	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Foley	Foley	JJ	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
61-year-old	61-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
obesity	obesity	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2006	2006	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sudden	sudden	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
function	function	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
lower	low	JJR	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
right	right	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Lihiltcat	Lihiltcat	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Neurology	Neurology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
an	an	DT	B-NP	O
MRI	MRI	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
internal	internal	JJ	I-NP	O
capsule	capsule	NN	I-NP	O
lacunar	lacunar	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TPA	TPA	NN	I-NP	O
window	window	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
EF	EF	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
thrombosis	thrombosis	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
a-fib	a-fib	NN	B-NP	B-DNA
.	.	.	O	O

His	His	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
with	with	IN	B-PP	O
Foley	Foley	NNP	B-NP	O
trauma	trauma	NN	I-NP	O
and	and	CC	I-NP	O
hematuria	hematuria	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
required	require	VBD	B-VP	O
continuous	continuous	JJ	B-NP	O
bladder	bladder	NN	I-NP	O
irrigation	irrigation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
by	by	IN	B-PP	O
UA	UA	NNP	B-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
culture	culture	NN	I-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
briefly	briefly	RB	B-ADVP	O
by	by	IN	B-PP	O
Urology	Urology	NNP	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
continued	continue	VBN	B-NP	O
bladder	bladder	NN	I-NP	O
irrigation	irrigation	NN	I-NP	O
and	and	CC	I-NP	O
followup	followup	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	B-protein
x3	x3	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
bladder	bladder	NN	I-NP	O
irrigation	irrigation	NN	I-NP	O
and	and	CC	O	O
urology	urology	NN	B-NP	O
followup	followup	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
UT	UT	NN	I-NP	O
urogram	urogram	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
fairly	fairly	RB	B-ADVP	O
well	well	RB	I-ADVP	O
in	in	IN	B-PP	O
rehab	rehab	NN	B-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2006	2006	CD	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
being	be	VBG	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
when	when	WRB	B-ADVP	O
,	,	,	O	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
session	session	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
accidentally	accidentally	RB	B-ADVP	O
manipulated	manipulate	VBD	B-VP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
causing	cause	VBG	B-VP	O
increased	increase	VBN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
hematuria	hematuria	NN	B-NP	O
.	.	.	O	O

So	So	RB	B-ADVP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
after	after	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
already	already	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2006	2006	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
but	but	CC	O	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
pelvic	pelvic	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
morphine	morphine	NN	I-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	NNP	B-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
,	,	,	O	O
Valium	Valium	NNP	B-NP	O
and	and	CC	O	O
Ativan	Ativan	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
became	become	VBD	B-VP	O
increasingly	increasingly	RB	B-ADJP	O
sedated	sedate	VBN	I-ADJP	O
and	and	CC	O	O
developed	develop	VBN	B-VP	O
an	an	DT	B-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
eventually	eventually	RB	B-ADVP	O
on	on	IN	B-PP	O
lung	lung	NN	B-NP	O
non-rebreather	non-rebreather	JJ	B-ADJP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medicine	medicine	NN	I-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	I-VP	O
sedated	sedate	VBN	I-VP	O
and	and	CC	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
arouse	arouse	VB	I-VP	O
.	.	.	O	O

ABGs	ABG	NNS	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
7.25	7.25	CD	I-NP	O
/	/	SYM	I-NP	O
71/90	71/90	CD	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
0.04	0.04	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Narcan	Narcan	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
immediately	immediately	RB	B-ADVP	O
awoke	awake	VBP	B-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
become	become	VB	I-VP	O
sedated	sedate	VBN	I-VP	O
within	within	IN	B-PP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
ICU	ICU	NN	B-NP	B-protein
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2006	2006	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Narcan	Narcan	NNP	B-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
only	only	RB	B-ADVP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
90s	90	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	B-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
KUB	KUB	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
gas	gas	NN	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
Narcan	Narcan	NNP	B-NP	O
boluses	bolus	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
ABG	ABG	NNP	I-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
7.33	7.33	CD	B-NP	O
/	/	SYM	B-PP	O
56/113	56/113	CD	B-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
non-rebreather	non-rebreather	JJ	B-ADJP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
overnight	overnight	JJ	I-NP	O
ICU	ICU	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Eventually	Eventually	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
maintaining	maintain	VBG	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
over	over	IN	B-PP	O
100	100	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
over	over	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	I-VP	O
awake	awake	VB	I-VP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
after	after	IN	B-SBAR	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
ICU	ICU	NN	B-NP	B-protein
overnight	overnight	RB	B-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
being	be	VBG	B-VP	O
over-narcotized	over-narcotized	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

Systolic	Systolic	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
boluses	bolus	NNS	B-NP	O
with	with	IN	B-PP	O
Narcan	Narcan	NN	B-NP	O
IV	IV	CD	I-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
above	above	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
normal	normal	JJ	B-ADJP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
before	before	IN	B-SBAR	O
and	and	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
usually	usually	RB	I-VP	O
maintained	maintain	VBN	I-VP	O
between	between	IN	B-PP	O
50	50	CD	B-NP	O
to	to	TO	B-PP	O
67	67	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
times	time	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
has	have	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
12.5	12.5	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
happened	happen	VBD	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
resumed	resume	VBD	B-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
captopril	captopril	NN	I-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
and	and	CC	B-PP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
3-4	3-4	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
cardiovascularly	cardiovascularly	RB	B-ADVP	O
and	and	CC	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
statin	statin	NN	B-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
non-rebreather	non-rebreather	JJ	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
stay	stay	NN	I-NP	O
from	from	IN	B-PP	O
ICU	ICU	NN	B-NP	B-protein
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
satting	satte	VBG	I-VP	O
well	well	RB	B-ADVP	O
between	between	IN	B-PP	O
96-97	96-97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3-4	3-4	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
lungs	lung	NNS	I-NP	O
have	have	VBP	B-VP	O
remained	remain	VBN	I-VP	O
cleared	cleared	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lasix	Lasix	NN	I-NP	O
has	have	VBZ	B-VP	O
resumed	resume	VBN	I-VP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
Lasix	Lasix	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
original	original	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
minimal	minimal	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
here	here	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
and	and	CC	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
sepsis	sepsis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
antibiotics	antibiotic	NNS	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
continued	continue	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

Urology	Urology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
hematuria	hematuria	NN	B-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
Foley	Foley	NNP	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
continued	continued	JJ	I-NP	O
bladder	bladder	NN	I-NP	O
irrigation	irrigation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

Under	Under	IN	B-PP	O
the	the	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
urologist	urologist	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
bladder	bladder	NN	I-NP	O
irrigation	irrigation	NN	I-NP	O
anymore	anymore	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
urologist	urologist	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
bladder	bladder	NN	I-NP	O
has	have	VBZ	B-VP	O
actually	actually	RB	I-VP	O
stopped	stop	VBN	I-VP	O
bleeding	bleed	VBG	I-VP	O
with	with	IN	B-PP	O
clear	clear	JJ	B-NP	O
urine	urine	NN	I-NP	O
drained	drain	VBD	B-VP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	I-VP	O
agitated	agitate	VBN	I-VP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
and	and	CC	O	O
pulled	pull	VBD	B-VP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
out	out	IN	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
created	create	VBD	B-VP	O
a	a	DT	B-NP	O
trauma	trauma	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bladder	bladder	NN	I-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
bleeding	bleeding	NN	I-NP	O
stopped	stop	VBD	B-VP	O
very	very	RB	B-ADVP	O
quickly	quickly	RB	I-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
urologist	urologist	NN	I-NP	O
placed	place	VBD	B-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
Foley	Foley	NNP	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
bladder	bladder	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
be	be	VB	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Anderson	Anderson	NNP	I-NP	O
Veley	Veley	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
their	their	PRP$	B-NP	O
opinion	opinion	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
urological	urological	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
4-5	4-5	NN	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
Urology	Urology	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
his	his	PRP$	B-NP	O
bladder	bladder	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stroke	stroke	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
before	before	IN	B-ADVP	O
,	,	,	O	O
so	so	IN	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
Foley	Foley	NNP	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
4-5	4-5	CD	I-NP	O
weeks	week	NNS	I-NP	O
until	until	IN	B-PP	O
followup	followup	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
urologist	urologist	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
29	29	CD	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Endocrinology	Endocrinology	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
NPH	NPH	NN	B-NP	B-protein
and	and	CC	O	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
recovered	recover	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
from	from	IN	B-PP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
0.7	0.7	CD	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-PP	O
void	void	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
created	create	VBD	B-VP	O
a	a	DT	B-NP	O
postrenal	postrenal	JJ	I-NP	O
azotemia	azotemia	NN	I-NP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
both	both	CC	O	O
prerenal	prerenal	JJ	B-NP	O
and	and	CC	I-NP	O
postrenal	postrenal	JJ	I-NP	O
azotemia	azotemia	NN	I-NP	O
have	have	VBP	B-VP	O
resolved	resolve	VBN	I-VP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
Mental	Mental	JJ	B-NP	O
status	status	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
very	very	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
occasionally	occasionally	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
side	side	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
lost	lose	VBN	I-VP	O
motor	motor	NN	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
left	leave	VBN	I-VP	O
hemiparesis	hemiparesis	NN	B-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
Neurontin	Neurontin	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	DT	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Neurology	Neurology	NNP	B-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2006	2006	CD	B-NP	O
.	.	.	O	O

Diet	Diet	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
diet	diet	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
resume	resume	VB	I-VP	O
his	his	PRP$	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Nexium	Nexium	NN	I-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Ambien	Ambien	IN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
for	for	IN	B-PP	O
sleep	sleep	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
responded	respond	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
Seroquel	Seroquel	NNP	B-NP	O
for	for	IN	B-PP	O
anti-anxiety	anti-anxiety	JJ	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pepcid	Pepcid	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
35	35	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
each	each	DT	B-NP	O
morning	morning	NN	I-NP	O
covered	cover	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
RISS	RISS	NN	I-NP	B-DNA
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
each	each	DT	B-NP	O
night	night	NN	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Ambien	Ambien	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
each	each	DT	B-NP	O
night	night	NN	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
live	live	VB	I-VP	O
in	in	IN	B-PP	O
Ryn	Ryn	NNP	B-NP	O
Pkwy	Pkwy	NNP	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
stroke	stroke	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
stay	stay	VB	I-VP	O
in	in	IN	B-PP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Diabetes	Diabetes	NN	B-NP	O
and	and	CC	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
stroke	stroke	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
gm	gm	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.i.d.	q.i.d.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Duoneb	Duoneb	IN	B-PP	O
3/0	3/0	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
inhalant	inhalant	JJ	I-NP	O
form	form	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Bacitracin	Bacitracin	NN	B-NP	O
and	and	CC	I-NP	O
neomycin	neomycin	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
topical	topical	JJ	I-NP	B-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Bacitracin	Bacitracin	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
meatus	meatus	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
continued	continue	VBN	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
,	,	,	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
-LRB-	-LRB-	FW	I-NP	O
hold	hold	NN	I-NP	O
is	be	VBZ	B-VP	O
systolic	systolic	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
95	95	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
resume	resume	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
discharge	discharge	NN	I-NP	O
medication	medication	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	O
aspartate	aspartate	NN	I-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
AC	AC	NN	I-NP	O
and	and	CC	O	O
hold	hold	VB	B-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
NPO	NPO	NN	B-NP	B-protein
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Novolog	Novolog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Nicotine	Nicotine	NN	B-NP	O
patch	patch	NN	I-NP	O
21	21	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Seroquel	Seroquel	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
bedtime	bedtime	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Ambien	Ambien	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
bedtime	bedtime	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-7495086	4-7495086	CD	B-NP	O
PSSten	PSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ANGON	ANGON	NNP	B-NP	O
,	,	,	O	O
CARMINE	CARMINE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GULLION	GULLION	NN	B-NP	O
,	,	,	O	O
ELISEO	ELISEO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7466596	7466596	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/10/06	10/10/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/10/06	10/10/06	CD	B-NP	O

